CULLINAN ONCOLOGY INC's ticker is CGEM and the CUSIP is 230031106. A total of 82 filers reported holding CULLINAN ONCOLOGY INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $176,285 | -18.5% | 19,479 | -3.1% | 0.00% | – |
| Q2 2023 | $216,362 | +96.7% | 20,108 | +87.1% | 0.00% | – |
| Q1 2023 | $109,973 | -3.0% | 10,750 | +0.0% | 0.00% | – |
| Q4 2022 | $113,381 | -16.0% | 10,747 | +1.7% | 0.00% | – |
| Q3 2022 | $135,000 | +0.7% | 10,563 | +1.4% | 0.00% | – |
| Q2 2022 | $134,000 | +2.3% | 10,419 | -15.9% | 0.00% | – |
| Q1 2022 | $131,000 | -35.8% | 12,389 | -6.1% | 0.00% | – |
| Q4 2021 | $204,000 | -5.1% | 13,187 | +38.3% | 0.00% | – |
| Q3 2021 | $215,000 | -7.7% | 9,534 | +5.6% | 0.00% | – |
| Q2 2021 | $233,000 | – | 9,031 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM BioImpact LLC | 7,648,268 | $118,013,000 | 21.52% |
| CHI Advisors LLC | 2,476,720 | $38,215,000 | 12.68% |
| Nextech Invest Ltd. | 1,221,145 | $18,842,000 | 4.96% |
| Foresite Capital Management V, LLC | 1,143,006 | $17,637,000 | 4.33% |
| Foresite Capital Opportunity Management V, LLC | 381,002 | $5,879,000 | 3.94% |
| BVF INC/IL | 5,369,459 | $82,851,000 | 3.01% |
| Boxer Capital, LLC | 1,074,082 | $16,573,000 | 0.64% |
| Logos Global Management LP | 288,458 | $4,450,000 | 0.46% |
| Birchview Capital, LP | 45,114 | $696,000 | 0.45% |
| Eventide Asset Management | 1,440,145 | $21,665,000 | 0.28% |